Dogwood Therapeutics Inc (DWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,333 | 7,031 | 9,788 | 7,695 | 11,352 |
| TOTAL | $6,521 | $8,370 | $10,858 | $9,040 | $12,550 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $6,521 | $8,370 | $10,858 | $9,040 | $12,550 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 135 | 573 | 679 | 666 | 331 |
| Accrued Expenses | 414 | 470 | 954 | 1,232 | 1,547 |
| TOTAL | $549 | $1,043 | $1,633 | $1,898 | $1,877 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $549 | $1,043 | $1,633 | $1,898 | $1,877 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 733 | 733 | 733 | 333 | 333 |
| Common Shares | 2 | 2 | 2 | 1 | 1 |
| Retained earnings | -57,690 | -56,173 | -54,129 | -51,553 | -47,886 |
| TOTAL | $5,971 | $7,327 | $9,225 | $7,142 | $10,673 |
| Total Liabilities And Equity | $6,521 | $8,370 | $10,858 | $9,040 | $12,550 |